Simrun Gill
Family Medicine · Pittsburgh, PANPI 1740468800
Payments from drug & device makers
Across 150 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$541
- Lilly USA, LLC$530
- Boehringer Ingelheim$493
- Novo Nordisk$356
- Johnson & Johnson$229
- Exact Sciences$164
- plus $692 from 10 others
What the payments were for
- Food & beverage$2,992100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $541 |
| Lilly USA, LLC | 23 | $530 |
| Boehringer Ingelheim | 22 | $493 |
| Novo Nordisk | 20 | $356 |
| Johnson & Johnson(2 entities) | 9 | $229 |
| Exact Sciences | 7 | $164 |
| Pfizer | 9 | $147 |
| Avanir Pharmaceuticals, Inc. | 7 | $122 |
| Kowa Pharmaceuticals America, Inc. | 6 | $110 |
| E.r. Squibb & Sons, L.L.C. | 6 | $82 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| AbbVie | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Amgen | 1 | $17 |
| Novartis | 1 | $17 |
How this compares
$3,004 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 20 | $20,381 |
| XareltoRivaroxaban | 11 | $5,746 |
| Pantoprazole Sodium | 42 | $593 |
| Alprazolam | 32 | $499 |
| Metoprolol Succinate | 19 | $469 |
| Omeprazole | 22 | $406 |
| Atorvastatin Calcium | 40 | $403 |
| Warfarin Sodium | 20 | $373 |
| Losartan Potassium | 44 | $334 |
| Hydroxyzine Hcl | 13 | $244 |
| Amlodipine Besylate | 26 | $244 |
| Levothyroxine Sodium | 19 | $239 |
| Rosuvastatin Calcium | 25 | $225 |
| Gabapentin | 12 | $222 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $212 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $493 | $20,38120 claims |
| Johnson & JohnsonXarelto | $229 | $5,74611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Pittsburgh
- Bryce PalchickPittsburgh$4.7M
- Shari RozenPittsburgh$2.9M
- Nathan BennettPittsburgh$1.6M
- James MorettiPittsburgh$1.5M
- Michael GatesPittsburgh$608K
- Daniel AustinPittsburgh$598K
- Norman KolbPittsburgh$81K
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.